TIBCS Agenda day 1
2017 Taipei International Breast Cancer Symposium2F, HuaNan Bank International Convention Center
Fri., September 29, 2017
Time / Topic / Speaker
Local Regional Therapy and Precision Medicine
13:00-13:20 / Opening / Shyr-Ming Sheen-Chen
13:20-13:40 / Satellite Symposium- Bard
When you need an excision biopsy / Sharon Wing-wai Chan
13:40-14:05 / Nipple sparing mastectomy and immediate one-stagereconstruction using breast implant / 南雲吉則
Nagumo Yoshinori
14:05-14:25 / 乳腺癌前哨淋巴結活檢：進展與展望 / 王永勝
Yongsheng Wang
14:25-14:45 / De-Escalation of Breast Cancer Surgery, but not forRelapse / 陳訓徹
Shin-Cheh Chen
14:45-15:10 / TBD / Louis Chow
15:10-15:30 / Break
15:30-15:50 / Systems Biology Data Science for Breast Cancer Therapy / 阮雪芬
Hsueh-Fen Juan
15:50-16:20 / Clinical application of CGP in breast cancer (TBC) / Tan Yew Oo
16:20-16:40 / How NGS lay the foundation for precision medicine in breast cancer? (TBC) / 余志宏
Chi Wang (Eric) Yu
16:40-17:10 / Satellite Symposium- Amwise
1. Racial difference of breast cancer genes
2. An 18-gene classifier vs. Oncotype DX in prognosis of breast cancer / 盧子彬
楊博勝
17:10-17:40 / Satellite Symposium- ACT Genomics
Applications of NGS in breast cancer management / 陳淑貞
Shu-Jen Chen
17:40-18:10 / Satellite Symposium-MSD
General Immuno-Oncology and Current Landscape of Immunotherapy for Breast Cancer / Giampaolo Bianchini
TIBCS Agenda day 2
2F, HuaNan Bank International Convention Center
Sat., September30, 2017
Time / Topic / Speaker
08:25-08:30 / Opening Ceremony / Shyr-Ming Sheen-Chen
The Breast Cancer Society of Taiwan
08:30-08:40 /
Shih-Chung ChenMinister of Health and Welfare
08:40-09:00 / Special LectureTowards the Reform of Taiwan’s National Health Insurance from the aspect of the Big Data Analysis / Po-Chang Lee
09:00-09:10 / Micro Film for the 20th anniversary of Breast Cancer Society of Taiwan
09:10-09:30 / Characteristics of Female Breast Cancer in East Asia / Ching-Hung Lin
09:30-09:50 / Breast MRI- Introduction of ACR BI-RADS Lexicon / Jane Wang
09:50-10:10 / The Management of Sentinel Lymph Node after Neoadjuvant Chemotherapy / Chiun-Sheng Huang
10:10-10:30 / Adjuvant radiotherapy for DCIS: defining the indication / Sung-Hsin Kuo
10:30-10:50 / Extended adjuvant treatment for ER+ EBC / Ta-Chung Chao
10:50-11:10 / Coffee Break
11:10-11:50 / Plenary Lecture-(1)
Breast Cancer Susceptibility: from genetic mutation to microenvironment adaptation / Wen-Hwa Lee
11:50-12:20 / Tumor Genomics & Precision Medicine: Incorporation into cancer care and clinical trials / Carlos L. Arteaga
12:20-13:00 / Luncheon Symposium- Amgen
Targeting the RANK pathway to manage complications from metastatic breast cancer / Yoland Antill
13:00-13:20 / Break
13:20-14:00 / Plenary Lecture-(2)
Mechanisms of resistance to endocrine therapy in ER+ breast cancer / Carlos L. Arteaga
14:00-14:30 / Satellite Symposium-Novartis
Targeting novel molecular pathway in HR+ advanced breast cancer / TBD
14:30-15:00 / Satellite Symposium-AZ
The role of endocrine therapy alone in targeted therapy era / Hwei-Chung Wang
15:00-15:20 / Coffee Break
15:20-16:00 / Plenary Lecture-(3)
The current status of cancer immunotherapy / Mary L. (Nora) Disis
16:00-16:30 / Oncoimmunology of breast cancer / Giuseppe Curigliano
16:30-17:00 / Immunotherapy for breast cancer and future perspectives / Giampaolo Bianchini
17:00-17:20 / Vaccine to eliminate breast cancer stem cells / Mary L. (Nora) Disis
TIBCS Agenda Day3
2F, HuaNan Bank International Convention Center
Sun., October 1, 2017
Time / Topic / Speaker
08:10-08:50 / Breakfast symposium -TTY
Oral 5-fu in Breast Cancer Treatment / Jyunji Turutani
09:00-09:40 / Plenary Lecture-(4)
Marker-Guided Combination Therapy with PARP Inhibitors and Immune Checkpoint Therapy / Mien-Chie Hung
09:40-10:10 / Satellite Symposium-Pfizer
Management of Palbociclib in HR+ HER2- metastatic Breast Cancer / Shaheenah Dawood
10:10-10:30 / Coffee Break
10:30-11:00 / Adjuvant treatment of HER2-positive breast cancer / Gunter von Minckwitz
11:00-11:30 / Biomarker Analysis for Treatment of HER2+ Disease / Giampaolo Bianchini
11:30-12:10 / Plenary Lecture-(5)
How is Neoadjuvant Chemotherapy being Used in Germany – Experiences within and without Clinical Trials of GBG / Gunter von Minckwitz
12:10-12:30 / Panel Discussion
Role of Neoadjuvant Chemotherapy Outside the Clinical Trial / Gunter von Minckwitz
William J. Gradishar
Giampaolo Bianchini
12:30-13:10 / Luncheon Symposium
Personalized Strategy in Management of HER2+ Metastatic Breast Cancer / William J. Gradishar
13:10-13:30 / Coffee Break
13:30-14:00 / Developmental Therapeutics for Patients with Breast Cancer and Central Nervous System Metastasis: Current landscape and Future Perspectives / William J. Gradishar
14:00-14:20 / Strategies for treatment of mTNBC / Ming-Shen Dai
14:20-14:50 / St Gallen Consensus Conference 2017 / Giuseppe Curigliano
14:50-15:20 / Satellite Symposium-Roche
Raise the bar- Immuno effect of anti-HER2 monoclonal antibody in breast cancer treatment / Ying-Wen Su
15:20-15:50 / Satellite Symposium-Roche
Harnessing the Power of Immunotherapy or Novel Targeted Therapy for non-HER2 Breast Cancer / Leisha A. Emens
15:50-16:20 / Satellite Symposium-Eisai / Kan Yonemori
16:20-16:40 / Discussion
16:40-16:50 / Closing / Shyr-Ming Sheen-Chen
2017 台北國際乳癌研討會
9月29日~10月1日(五~日)華南銀行總行2樓國際會議中心
報名表
1、 基本資料(以下資料缺一不可，請務必填寫字跡工整，以免建檔有誤影響您的權利，不敷使用，請自行影印)
姓名: 英文姓名: 會員編號:(如不知可不寫)身分證字號: 出生年月日: : 年 月 日
(以上資料請必填入，如遺漏，恕無法完整登錄積分)
服務醫院: 單位: 職稱:
身分別:□醫師□藥師□護理師□專科護理師□放射師□醫檢師□其他人員:
收據抬頭: (如需才寫) 統一編號: (如需才寫)
聯絡地址(必填):□□□□□
聯絡電話(必填): 手機:
電子信箱(必填):
身分別 / □團體報名價
(即日起~8/31) / □早鳥票價
(即日起~9/15) / □現場報名價
(9/16~10/1)
□乳房醫學會會員 / $800 / $900 / $1500
□非會員醫師 (非乳醫會員、廠商) / $1600 / $2000 / $2500
□非會員(包含藥師、護理人員、放射師、住院醫師、醫學系實習生、研究人員等) / $500 / $600 / $1000
1. 日期以匯款日期為主
2. 團體報名注意事項
1).需湊滿10人(含以上)，需「一次一起」E-mail或傳真報名表並附上繳款收據至學會，
不限醫院，不限身分，湊滿10人即團報價。傳真完請務必來電確認是否報名成功。
2).每人都需填寫報名表，以上資料都需填寫完成並附上繳費收據，再一起傳真。
3. 報名表與匯款單收據須同時傳真或E-mail 才算報名成功。
二、繳費方式:
請至郵局郵政劃撥:50027647，戶名:台灣乳房醫學會，註明:報名9/29-10/1 2017 台北國際乳癌研討會
三、退費規定: 因故無法參加，請於9/1(五)前申請退費，將核退報名費80%，9/2(六)後申請，恕不退費，謝謝您的配合。